Although little work has been performed to harness the therapeutic potential of PTEN-Long in prostate cancer, purified PTEN-Long (but not purified PTEN) has been shown to inhibit tumor proliferation and induce tumor regression in a clear cell renal cell carcinoma xenograft model in vivo [105]. The gene discussed is PTEN; the disease is prostate carcinoma.